Literature DB >> 30807218

A Systematic Review of the Existing Prostate Imaging Reporting and Data System Version 2 (PI-RADSv2) Literature and Subset Meta-Analysis of PI-RADSv2 Categories Stratified by Gleason Scores.

Emil Jernstedt Barkovich1, Prasad R Shankar2, Antonio C Westphalen3,4.   

Abstract

OBJECTIVE: The objective of this study was to quantitatively and qualitatively assess the methodologic heterogeneity of the current Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) literature and estimate the proportions of Gleason scores (GSs) diagnosed across PI-RADSv2 categories.
MATERIALS AND METHODS: This study was a systematic review and meta-analysis and was performed in concordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Only English-language studies and studies published before April 1, 2018, were assessed. The primary outcome of the meta-analysis was the estimated percentage of patients with GS ≥ 3 + 4 within each individual PI-RADSv2 score. We calculated the pooled estimates and 95% CIs on the basis of a random-effects model using the meta-analysis routine of Stata (version 13.1).
RESULTS: Our search revealed 434 titles, and 59 of these studies were selected. These studies were remarkable for their technical and terminological diverseness. Thirteen studies had sufficient data to be included in the meta-analysis. The prevalence of ≥ GS 3 + 4 in lesions assigned a PI-RADSv2 score of 3 or higher was approximately 45%. Lesions assigned PI-RADSv2 scores 1 or 2, 3, 4, and 5 represented high-grade disease in approximately 6%, 12%, 48%, and 72% of patients.
CONCLUSION: The data available in the literature are highly heterogeneous and challenging to analyze because of variations in terminology, patient cohort selection, criteria, imaging parameters, and reference standards. In spite of this heterogeneity, our meta-analysis shows that PI-RADSv2 has good sensitivity when a score of ≥ 3 is considered as a positive test.

Entities:  

Keywords:  Prostate Imaging Reporting and Data System (PI-RADS); Prostate Imaging Reporting and Data System version 2 (PI-RADSv2); multiparametric MRI (mpMRI); prostate imaging

Year:  2019        PMID: 30807218     DOI: 10.2214/AJR.18.20571

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  14 in total

Review 1.  PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.

Authors:  Anwar R Padhani; Jelle Barentsz; Geert Villeirs; Andrew B Rosenkrantz; Daniel J Margolis; Baris Turkbey; Harriet C Thoeny; François Cornud; Masoom A Haider; Katarzyna J Macura; Clare M Tempany; Sadhna Verma; Jeffrey C Weinreb
Journal:  Radiology       Date:  2019-06-11       Impact factor: 11.105

2.  Prostate MRI and quality: lessons learned from breast imaging rad-path correlation.

Authors:  Prasad R Shankar; Matthew S Davenport; Mark A Helvie
Journal:  Abdom Radiol (NY)       Date:  2020-12

3.  Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.

Authors:  Antonio C Westphalen; Charles E McCulloch; Jordan M Anaokar; Sandeep Arora; Nimrod S Barashi; Jelle O Barentsz; Tharakeswara K Bathala; Leonardo K Bittencourt; Michael T Booker; Vaughn G Braxton; Peter R Carroll; David D Casalino; Silvia D Chang; Fergus V Coakley; Ravjot Dhatt; Steven C Eberhardt; Bryan R Foster; Adam T Froemming; Jurgen J Fütterer; Dhakshina M Ganeshan; Mark R Gertner; Lori Mankowski Gettle; Sangeet Ghai; Rajan T Gupta; Michael E Hahn; Roozbeh Houshyar; Candice Kim; Chan Kyo Kim; Chandana Lall; Daniel J A Margolis; Stephen E McRae; Aytekin Oto; Rosaleen B Parsons; Nayana U Patel; Peter A Pinto; Thomas J Polascik; Benjamin Spilseth; Juliana B Starcevich; Varaha S Tammisetti; Samir S Taneja; Baris Turkbey; Sadhna Verma; John F Ward; Christopher A Warlick; Andrew R Weinberger; Jinxing Yu; Ronald J Zagoria; Andrew B Rosenkrantz
Journal:  Radiology       Date:  2020-04-21       Impact factor: 11.105

4.  The impeded diffusion fraction quantitative imaging assay demonstrated in multi-exponential diffusion phantom and prostate cancer.

Authors:  Dariya I Malyarenko; Scott D Swanson; Sean D McGarry; Peter S LaViolette; Thomas L Chenevert
Journal:  Magn Reson Med       Date:  2021-11-14       Impact factor: 4.668

5.  MRI-targeted biopsy cores from prostate index lesions: assessment and prediction of the number needed.

Authors:  Nick Lasse Beetz; Franziska Dräger; Charlie Alexander Hamm; Seyd Shnayien; Madhuri Monique Rudolph; Konrad Froböse; Sefer Elezkurtaj; Matthias Haas; Patrick Asbach; Bernd Hamm; Samy Mahjoub; Frank Konietschke; Maximilian Wechsung; Felix Balzer; Hannes Cash; Sebastian Hofbauer; Tobias Penzkofer
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-10-08       Impact factor: 5.455

6.  Structured approach to resolving discordance between PI-RADS v2.1 score and targeted prostate biopsy results: an opportunity for quality improvement.

Authors:  Rohith Arcot; Sitharthan Sekar; Srinath Kotamarti; Madison Krischak; Zoe D Michael; Wen-Chi Foo; Jiaoti Huang; Thomas J Polascik; Rajan T Gupta
Journal:  Abdom Radiol (NY)       Date:  2022-06-08

Review 7.  The current role of MRI for guiding active surveillance in prostate cancer.

Authors:  Guillaume Ploussard; Olivier Rouvière; Morgan Rouprêt; Roderick van den Bergh; Raphaële Renard-Penna
Journal:  Nat Rev Urol       Date:  2022-04-07       Impact factor: 16.430

8.  Technical note: Temperature and concentration dependence of water diffusion in polyvinylpyrrolidone solutions.

Authors:  Ghoncheh Amouzandeh; Thomas L Chenevert; Scott D Swanson; Brian D Ross; Dariya I Malyarenko
Journal:  Med Phys       Date:  2022-03-03       Impact factor: 4.506

Review 9.  Rethinking prostate cancer screening: could MRI be an alternative screening test?

Authors:  David Eldred-Evans; Henry Tam; Heminder Sokhi; Anwar R Padhani; Mathias Winkler; Hashim U Ahmed
Journal:  Nat Rev Urol       Date:  2020-07-21       Impact factor: 14.432

Review 10.  The use of prostate MR for targeting prostate biopsies.

Authors:  R Phelps Kelley; Ronald J Zagoria; Hao G Nguyen; Katsuto Shinohara; Antonio C Westphalen
Journal:  BJR Open       Date:  2019-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.